Medmonk
Medmonk is a technology-driven company specializing in patient support services for rare disease therapies. Founded in 2012 and incubated by Y Combinator, Medmonk offers a platform that automates patient enrollment and copay assistance, integrating with 98% of US pharmacies, buy & bill facilities, and infusion centers. Their solutions include automated eBV + ePA, copay assistance, PAP services, and data analytics, tailored to enhance patient access, adherence, and speed to therapy. Medmonk's approach combines deep pharmacy expertise, extensive specialty pharmacy network, and customizable support programs, achieving an average brand retention of seven years and assisting over 10 million patients since inception. Their technology is SOC 2 certified and includes proprietary AI capabilities launched in 2024, positioning Medmonk as a leader in patient financial support and hub services for pharmaceutical brands.
Medmonk
Medmonk is a technology-driven company specializing in patient support services for rare disease therapies. Founded in 2012 and incubated by Y Combinator, Medmonk offers a platform that automates patient enrollment and copay assistance, integrating with 98% of US pharmacies, buy & bill facilities, and infusion centers. Their solutions include automated eBV + ePA, copay assistance, PAP services, and data analytics, tailored to enhance patient access, adherence, and speed to therapy. Medmonk's approach combines deep pharmacy expertise, extensive specialty pharmacy network, and customizable support programs, achieving an average brand retention of seven years and assisting over 10 million patients since inception. Their technology is SOC 2 certified and includes proprietary AI capabilities launched in 2024, positioning Medmonk as a leader in patient financial support and hub services for pharmaceutical brands.